about
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolismGlucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor.Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.Proton therapy radiation pneumonitis local dose-response in esophagus cancer patientsMolecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?Planning evaluation of C-arm cone beam CT angiography for target delineation in stereotactic radiation surgery of brain arteriovenous malformations.High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.Dynamic changes during the treatment of pancreatic cancer.4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic ProgressionExosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicityOncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor MicroenvironmentCirculating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
P50
Q28834389-0EB2EE0F-F435-4A38-9BB9-CD1E2A109BABQ34746192-5590DF52-7631-4050-975D-65F101AD4FCEQ36716660-CD17020D-0EB2-45B0-B6F5-552360D25D5CQ36968104-424FAE2D-97B4-4454-B338-ADF9C66469B7Q38788235-B2DFE278-CA08-48AE-98D1-6524E8033AB0Q40206978-28F26DCF-F46E-4C57-A1FF-6E1AFD0D9AABQ40372616-23B05D48-F3A8-4149-9F2F-226B8D951AD7Q47633338-2FDE5C5F-66D5-43B2-A6EE-FA12DC2F25D2Q48631901-14F9E531-F3CD-4F89-9900-0D7B651D33C2Q52620434-C9A25A98-4A6B-4C9B-95F0-DE04C91828EAQ54139665-3E9D5FAD-98ED-47BC-B84A-74E6630B2986Q58548008-6739CF58-8482-4894-A7E1-68E961C66AC8Q60907747-F2BE3405-CC94-4DC9-82A0-983B1FB60DD5Q89663159-B539F263-2D7A-4AE6-A8C8-405D122F5906Q91626171-1DE1B9FD-2151-4411-98FC-00245CEF80F7
P50
description
researcher ORCID ID = 0000-0003-1555-608X
@en
wetenschapper
@nl
name
Vincent Bernard
@ast
Vincent Bernard
@en
Vincent Bernard
@es
Vincent Bernard
@nl
type
label
Vincent Bernard
@ast
Vincent Bernard
@en
Vincent Bernard
@es
Vincent Bernard
@nl
prefLabel
Vincent Bernard
@ast
Vincent Bernard
@en
Vincent Bernard
@es
Vincent Bernard
@nl
P106
P1153
37030500700
57188732044
P31
P496
0000-0003-1555-608X